OS Therapies Inc (OSTX) stock
OSTXNYSEPharmaceutical PreparationsFiscal year ends December 31
$0.74+0.06 (+9.42%)
Close on Nov 17, 2026Market cap $34.35MP/E –Yield –
OS Therapies operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
OS Therapies's operating cash flow for the twelve months ending Jun 30, 2026 was -$18.53M. For fiscal 2025 it was -$14.24M.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$14.24M | – |
| FY2024 | Dec 31, 2024 | -$7.28M | – |
| FY2023 | Dec 31, 2023 | -$3.01M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$5.53M | – |
| Q1 FY2026 | Mar 31, 2026 | -$4.56M | – |
| Q4 FY2025 | Dec 31, 2025 | -$3.73M | – |
| Q3 FY2025 | Sep 30, 2025 | -$4.71M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.36M | – |
| Q1 FY2025 | Mar 31, 2025 | -$3.44M | – |
| Q4 FY2024 | Dec 31, 2024 | -$2.37M | – |
| Q3 FY2024 | Sep 30, 2024 | -$3.38M | – |
| Q2 FY2024 | Jun 30, 2024 | -$881.19K | – |
| Q1 FY2024 | Mar 31, 2024 | -$641.73K | – |
| Q4 FY2023 | Dec 31, 2023 | -$871.16K | – |
| Q3 FY2023 | Sep 30, 2023 | -$876.57K | – |
| Q2 FY2023 | Jun 30, 2023 | -$831.05K | – |
| Q1 FY2023 | Mar 31, 2023 | -$428.19K | – |
See a number that looks wrong?